{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:03:11Z","timestamp":1790809391872,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.ajo.2009.07.021","type":"journal-article","created":{"date-parts":[[2009,10,18]],"date-time":"2009-10-18T04:08:14Z","timestamp":1255838894000},"page":"946-950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Scleritis and Systemic Disease Association in a Community-Based Referral Practice"],"prefix":"10.1016","volume":"148","author":[{"given":"Veena Rao","family":"Raiji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan Gary","family":"Palestine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Leland","family":"Parver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2009.07.021_bib1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0161-6420(95)30970-0","article-title":"Scleritis associated with systemic vasculitic diseases","volume":"102","author":"Sainz de la Maza","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.07.021_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ophtha.2003.06.006","article-title":"Evaluation of patients with scleritis for systemic disease","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.07.021_bib3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.survophthal.2005.04.001","article-title":"Scleritis","volume":"50","author":"Okhravi","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2009.07.021_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9394(00)00710-8","article-title":"Episcleritis and scleritis: clinical features and treatment results","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.07.021_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.60.3.163","article-title":"Scleritis and Episcleritis","volume":"60","author":"Watson","year":"1976","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.07.021_bib6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0161-6420(99)90157-4","article-title":"Severity of episcleritis and systemic disease association","volume":"106","author":"Akpek","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.07.021_bib7","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/S0161-6420(99)90543-2","article-title":"Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients","volume":"106","author":"McCluskey","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.07.021_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ncprheum0454","article-title":"Therapy insight: scleritis and its relationship to systemic autoimmune disease","volume":"3","author":"Smith","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.ajo.2009.07.021_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ajo.2007.09.024","article-title":"Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis","volume":"145","author":"Lin","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.07.021_bib10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/archopht.126.5.651","article-title":"Anti-neutrophil cytoplasmic antibody\u2013associated active scleritis","volume":"126","author":"Hoang","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2009.07.021_bib11","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0161-6420(03)00570-0","article-title":"Mycophenolate mofetil for the treatment of scleritis","volume":"110","author":"Sen","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.07.021_bib12","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.ophtha.2005.02.020","article-title":"Mycophenolate mofetil therapy for inflammatory eye disease","volume":"112","author":"Thorne","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.07.021_bib13","first-page":"1955","article-title":"Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents","volume":"31","author":"Mohan","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ajo.2009.07.021_bib14","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1053\/j.ajkd.2007.10.043","article-title":"ANCA-associated renal vasculitis following anti\u2013tumor necrosis factor therapy","volume":"51","author":"Simms","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ajo.2009.07.021_bib15","first-page":"1885","article-title":"Tumor necrosis factor-alpha blockade and the risk of vasculitis","volume":"31","author":"Guillevin","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ajo.2009.07.021_bib16","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.ophtha.2007.12.011","article-title":"Mycophenolate mofetil after methotrexate failure of intolerance in the treatment of scleritis and uveitis","volume":"115","author":"Sobrin","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.07.021_bib17","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory diseases: recommendations from an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.07.021_bib18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0161-6420(99)90078-7","article-title":"Mycophenolate mofetil","volume":"106","author":"Larkin","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.07.021_bib19","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0161-6420(03)00092-7","article-title":"Mycophenolate mofetil as immunomodulatory agent in the treatment of chronic ocular inflammatory disorders","volume":"110","author":"Baltatzis","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.07.021_bib20","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0002-9394(02)01814-7","article-title":"Severe scleritis and urticarial lesions","volume":"134","author":"Thorne","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.07.021_bib21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-2001-14917","article-title":"Early clinical results with mycophenolate mofetil in immunosuppressive therapy of ocular pemphigoid [in German]","volume":"218","author":"Zurdel","year":"2001","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.ajo.2009.07.021_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0140-6736(05)79515-5","article-title":"Rescue therapy with mycophenolate mofetil in refractory uveitis","volume":"352","author":"Kilmartin","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ajo.2009.07.021_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archopht.120.1.15","article-title":"Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy","volume":"120","author":"Sainz de la Maza","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2009.07.021_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0002-9394(02)01840-8","article-title":"Scleritis and other ocular side effects associated with pamidronate disodium","volume":"135","author":"Fraunfelder","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.07.021_bib25","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJM200303203481225","article-title":"Bisphosphonates and ocular inflammation","volume":"348","author":"Fraunfelder","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2009.07.021_bib26","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/IAE.0b013e31816576ef","article-title":"Post-marketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort","volume":"28","author":"French","year":"2008","journal-title":"Retina"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939409005194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939409005194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:00:02Z","timestamp":1757595602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939409005194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0002939409005194"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2009.07.021","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scleritis and Systemic Disease Association in a Community-Based Referral Practice","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2009.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}